Vijay Pandey

Development of Piperazine- and Oxazine-Linked Pyrimidines as p65 Subunit Binders of NF–κB in Human Breast Cancer Cells

P. Lobie, S. Gaonkar, Divakar Vishwanath, 2023, Biomedicines.

Depleted-MLH1 Expression Predicts Prognosis and Immunotherapeutic Efficacy in Uterine Corpus Endometrial Cancer: An In Silico Approach

Peng Huang, Tesfaye Wolde, Vijay Pandey, 2024, BioMedInformatics.

Concurrent inhibition of pBADS99 synergistically improves MEK inhibitor efficacy in KRASG12D-mutant pancreatic ductal adenocarcinoma

P. Lobie, Y. Tan, Xi Zhang, 2024, Cell death & disease.

Vertical pathway inhibition of receptor tyrosine kinases and BAD with synergistic efficacy in triple negative breast cancer

P. Lobie, Dukanya Dukanya, Y. Tan, 2024, NPJ precision oncology.

Development of Novel Indole and Coumarin Derivatives as Antibacterial Agents That Target Histidine Kinase in S. aureus

A. Sukhorukov, S. Gaonkar, N. Shivananju, 2023, Applied Microbiology.

Combining Mitomycin C with inhibition of BAD phosphorylation enhances apoptotic cell death in advanced cervical cancer

P. Lobie, Xi Zhang, Shu Chen, 2024, Translational oncology.